Medical specialists from France tagged as investigators in clinical trials studying Leukemia, Lymphocytic, Chronic, B-Cell
Total 62 results
-
Agathe Waultier RascalouSeen in:
- Nimes, Chu Nimes/Institut De Cancerologie Du Gard
- Nimes, Nîmes, Chu Nimes/Institut De Cancerologie Du Gard
Trials:- NCT04666038 (Principal Investigator)
- NCT05023980 (Principal Investigator)
Conditions: -
Ambroise Marçais, MDSeen in:
- Paris, Service d'Hématologie Adultes Hôpital Necker
Trials:- NCT04935684 (Principal Investigator)
-
Amorim SandySeen in:
- Lille cedex, Hopital Saint Vincent De Paul
Trials:- NCT04662255 (Principal Investigator)
- NCT04666038 (Principal Investigator)
-
Anna BorraSeen in:
- Nice Cedex 2, Nice, Centre Antoine Lacassagne
Trials:- NCT05254743 (Principal Investigator)
-
Anne LokSeen in:
- Cedex 1, Nantes, CHU de Nantes - Hotel Dieu
- Cedex 1, Nantes, CHU de Nantes - Hôtel-Dieu
Trials:- NCT04965493 (Principal Investigator)
- NCT05254743 (Principal Investigator)
-
Anne QUINQUENELSeen in:
- Reims, CHU de Reims
Trials:- NCT05246345 (Principal Investigator)
-
Anne-Lise Menard, MDSeen in:
- Rouen, Département d'hématologie CAC Rouen
Trials:- NCT04935684 (Principal Investigator)
-
Anne-Sophie MICHALLETSeen in:
- Lyon, Centre Leon Bérard
Trials:- NCT05246345 (Principal Investigator)
-
Annie BrionSeen in:
- Besançon, CHU de Besançon
Trials:- NCT05246345 (Principal Investigator)
-
Aurélie Ravinet, MDSeen in:
- Clermont-Ferrand, CHU Estaing
- Clermont-Ferrand, Service de thérapie Cellulaire et d'Hématologie Clinique Adulte CHU Estaing - Clermont-Ferrand
Trials:- NCT03439371 (Sub-Investigator)
- NCT04935684 (Sub-Investigator)
-
Bruno VillemagneSeen in:
- La Roche Sur Yon, La Roche-sur-Yon, CHD Vendee
- La Roche sur Yon Cedex 9, GSK Investigational Site
- La Roche sur Yon, CHD Vendee
- Vendee, La Roche-sur-Yon, CHD Vendee
Trials:- NCT05263934 (Principal Investigator)
- NCT04666038 (Principal Investigator)
- NCT05023980 (Principal Investigator)
- NCT05254743 (Principal Investigator)
-
Carmen Botella Garcia, MDSeen in:
- Pessac, Hématologie clinique et thérapie cellulaire Hôpital Haut-Lévèque
Trials:- NCT04935684 (Principal Investigator)
-
Caroline DartigeasSeen in:
- Tours Cedex 9, Tours, CHRU de Tours
- Tours Cedex 9, Tours, CHU Tours - Hôpital Bretonneau
Trials:- NCT04662255 (Principal Investigator)
- NCT04965493 (Principal Investigator)
- NCT04666038 (Principal Investigator)
- NCT05023980 (Principal Investigator)
- NCT05254743 (Principal Investigator)
-
Caroline MAYEUR-ROUSSE, MDSeen in:
- Strasbourg, Hematology Laboratory - Strasbourg University Hospitals
Trials:- NCT04952974 (Sub-Investigator)
-
Cecile TomowiakSeen in:
- Politiers, Pole Regionalde Cancérologie(CHU de Poitiers)
Trials:- NCT04965493 (Principal Investigator)
- NCT04666038 (Principal Investigator)
Conditions: -
Christian Dualé, MD, PhDSeen in:
- Clermont-Ferrand, Plateforme d'Investigation Clinique / Centre d'Investigation Clinique - Inserm 1405, CHU Gabriel Montpied Clermont-Ferrand
Trials:- NCT04935684 (Principal Investigator)
-
Claude-Eric Bulabois, MDSeen in:
- Grenoble, Service hématologie CHU Grenoble
Trials:- NCT04935684 (Principal Investigator)
-
Damien Roos-WeilSeen in:
- Cedex 13, Paris, Groupe Hospitalier Pitie-Salpetriere
- Cedex 13, Paris, Hopital de la Pitie Salpetriere
- Paris, Hôpital Pitié Salpêtrière
Trials:- NCT04965493 (Principal Investigator)
- NCT05254743 (Principal Investigator)
- NCT05246345 (Principal Investigator)
-
David Beauvais, MDSeen in:
- Lille, Service des Maladies du sang Hôpital HURIEZ, CHRU de Lille
Trials:- NCT04935684 (Principal Investigator)
-
Deborah Desmier, MDSeen in:
- Poitiers, Service d'hématologie greffe Hôpital St Louis
Trials:- NCT04935684 (Principal Investigator)
-
Emmanuelle FerrantSeen in:
- Cedex, Pierre Benite, Centre Hospitalier Lyon Sud
- Cedex, Pierre-Bénite, Centre Hospitalier Lyon Sud
Trials:- NCT04965493 (Principal Investigator)
- NCT05254743 (Principal Investigator)
-
Emmanuelle TAVERNIER, MDSeen in:
- Saint-Étienne, CHU SAINT-ETIENNE
- Saint-Étienne, Hématologie clinique Institut de Cancérologie de la Loire
Trials:- NCT03481868 (Principal Investigator)
- NCT04935684 (Principal Investigator)
-
Emmanuelle TchernonogSeen in:
- Herault, Montpellier Cedex 5, Hopital Saint Eloi
- Montpellier, CHU de Montpellier
Trials:- NCT04965493 (Principal Investigator)
- NCT05246345 (Principal Investigator)
-
Etienne Daguindau, MDSeen in:
- Besançon, Hématologie clinique CHU Besançon
Trials:- NCT04935684 (Principal Investigator)
-
Florence CymbalistaSeen in:
- Cedex, Bobigny, Hospital AVICENNE
Trials:- NCT04666038 (Principal Investigator)
Conditions: -
Florence SabirouSeen in:
- Vienne, Politiers, CHU Poitiers - Hôpital la Milétrie
Trials:- NCT04965493 (Principal Investigator)
Conditions: -
Guillaume CartronSeen in:
- Montpellier Cedex, Hopital Saint Eloi
- Montpellier, Hematology department - UHMontpellier Saint éloi
Trials:- NCT04965493 (Principal Investigator)
- NCT02134574 (Principal Investigator)
-
Hussam SaadSeen in:
- Brest cedex, CHRU de Brest - Hôpital Morvan
- Brest, CHRU de Brest
Trials:- NCT04666038 (Principal Investigator)
- NCT02645825 (Principal Investigator)
-
Jacques-Olivier Bay, MD, PhDSeen in:
- Clermont-Ferrand, Service de thérapie Cellulaire et d'Hématologie Clinique Adulte CHU Estaing - Clermont-Ferrand
Trials:- NCT04935684 (Principal Investigator)
-
Jean i Marc ZinSeen in:
- Paris, Paris cedex 10, Hopital Saint-Louis
Trials:- NCT04965493 (Principal Investigator)
Conditions:
Clinical Trials on Leukemia, Lymphocytic, Chronic, B-Cell
-
National Heart, Lung, and Blood Institute (NHLBI)Active, not recruitingLeukemia, Lymphocytic, Chronic, B-Cell | Chronic Lymphocytic Leukemia | Leukemia, Chronic Lymphatic | B-Cell Chronic Lymphocytic Leukemia | Leukemia, Lymphocytic, Chronic | B-Lymphocytic Leukemia, Chronic | Leukemia, Chronic Lymphocytic, B-Cell | Lymphocytic Leukemia, Chronic, B Cell | Lymphocytic Leukemia...United States
-
National Cancer Institute (NCI)CompletedB-cell Chronic Lymphocytic Leukemia | Refractory Chronic Lymphocytic LeukemiaUnited States
-
Fred Hutchinson Cancer Research Center/University...WithdrawnB-cell Chronic Lymphocytic Leukemia | Refractory Chronic Lymphocytic Leukemia
-
French Innovative Leukemia OrganisationTerminatedB-cell Chronic Lymphocytic Leukemia (B-CLL)France
-
Genzyme, a Sanofi CompanyBayer Healthcare Pharmaceuticals, Inc./Bayer Schering PharmaCompletedB-Cell Chronic Lymphocytic Leukemia (B-CLL)United Kingdom, Belgium, France, United States, Czech Republic, Serbia
-
Shanghai Zhangjiang Biotechnology Limited CompanySuspendedB-cell Chronic Lymphocytic LeukemiaChina
-
Mundipharma Research LimitedTerminatedB-cell Chronic Lymphocytic LeukemiaSpain
-
CelgeneCompletedB-cell Chronic Lymphocytic LeukemiaUnited States, Spain, United Kingdom, Canada, Belgium, Czechia, Hungary, Italy, Poland, Israel, Germany, Ireland, France, New Zealand, Denmark, Australia, Netherlands, Romania, Russian Federation, Sweden, Austria, South Africa, Colo... and more
-
French Innovative Leukemia OrganisationRoche Pharma AGCompletedB-cell Chronic Lymphocytic Leukemia CLLFrance
-
OnxeoCompletedB-cell Chronic Lymphocytic LeukemiaUnited Kingdom